De Bandt D, Rives-Lange C, Frigout Y, Bergerot D, Blanchard A, Le Gall M, et al
The gradual dose increase is specifically designed to help minimise these effects
GLP-1s like Ozempic, Wegovy, Semaglutide, Mounjaro, Zepbound, Tirzepatide, Liraglutide, Saxenda, Trulicity, and Victoza introduce a unique interplay that heightens the risk of dehydration through various mechanisms: Enhanced urinary output: GLP-1 therapy often amplifies urinary frequency as a consequence of its blood sugar-lowering effects
Trimethylamine N-oxide: the good, the bad and the unknown
Month 1 is also the time to identify which foods work well and which cause problems